BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38751338)

  • 1. Toward microfluidic continuous-flow and intelligent downstream processing of biopharmaceuticals.
    Sharma V; Mottafegh A; Joo JU; Kang JH; Wang L; Kim DP
    Lab Chip; 2024 May; 24(11):2861-2882. PubMed ID: 38751338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microfluidic platform for rapid screening of bacterial cell lysis.
    Fradique R; Azevedo AM; Chu V; Conde JP; Aires-Barros MR
    J Chromatogr A; 2020 Jan; 1610():460539. PubMed ID: 31543341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensors and chemometrics in downstream processing.
    Dürauer A; Jungbauer A; Scharl T
    Biotechnol Bioeng; 2023 Jul; ():. PubMed ID: 37470278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toward Personalized Cancer Treatment: From Diagnostics to Therapy Monitoring in Miniaturized Electrohydrodynamic Systems.
    Khondakar KR; Dey S; Wuethrich A; Sina AA; Trau M
    Acc Chem Res; 2019 Aug; 52(8):2113-2123. PubMed ID: 31293158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biopharmaceutical Manufacturing: Historical Perspectives and Future Directions.
    Szkodny AC; Lee KH
    Annu Rev Chem Biomol Eng; 2022 Jun; 13():141-165. PubMed ID: 35300518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microfluidic Devices as Process Development Tools for Cellular Therapy Manufacturing.
    Aranda Hernandez J; Heuer C; Bahnemann J; Szita N
    Adv Biochem Eng Biotechnol; 2022; 179():101-127. PubMed ID: 34410457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous integrated manufacturing for biopharmaceuticals: A new paradigm or an empty promise?
    Rathore AS; Thakur G; Kateja N
    Biotechnol Bioeng; 2023 Feb; 120(2):333-351. PubMed ID: 36111450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Developments and opportunities in continuous biopharmaceutical manufacturing.
    Khanal O; Lenhoff AM
    MAbs; 2021; 13(1):1903664. PubMed ID: 33843449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-time detection of mAb aggregates in an integrated downstream process.
    São Pedro MN; Isaksson M; Gomis-Fons J; Eppink MHM; Nilsson B; Ottens M
    Biotechnol Bioeng; 2023 Oct; 120(10):2989-3000. PubMed ID: 37309984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expediting online liquid chromatography for real-time monitoring of product attributes to advance process analytical technology in downstream processing of biopharmaceuticals.
    Graf T; Naumann L; Bonnington L; Heckel J; Spensberger B; Klein S; Brey C; Nachtigall R; Mroz M; Hogg TV; McHardy C; Martinez A; Braaz R; Leiss M
    J Chromatogr A; 2024 Aug; 1729():465013. PubMed ID: 38824753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospects of Microfluidic Technology in Nucleic Acid Detection Approaches.
    Mumtaz Z; Rashid Z; Ali A; Arif A; Ameen F; AlTami MS; Yousaf MZ
    Biosensors (Basel); 2023 May; 13(6):. PubMed ID: 37366949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microfluidic-integrated DNA nanobiosensors.
    Ansari MIH; Hassan S; Qurashi A; Khanday FA
    Biosens Bioelectron; 2016 Nov; 85():247-260. PubMed ID: 27179566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current challenges in biotherapeutic particles manufacturing.
    Moleirinho MG; Silva RJS; Alves PM; Carrondo MJT; Peixoto C
    Expert Opin Biol Ther; 2020 May; 20(5):451-465. PubMed ID: 31773998
    [No Abstract]   [Full Text] [Related]  

  • 14. Fully integrated downstream process to enable next-generation manufacturing.
    Ramos I; Sharda N; Villafana R; Hill-Byrne K; Cai K; Pezzini J; Coffman J
    Biotechnol Bioeng; 2023 Jul; 120(7):1869-1881. PubMed ID: 36950907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
    Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
    J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recommendations for Enhancing Quality and Capability of Indian Biopharmaceutical Industry: Summary of a Workshop.
    Uppal A; Koduri CK; Yadlapalli S; Chirmule N; Chakrabarti R; Atouf F
    J Pharm Sci; 2020 Oct; 109(10):2958-2961. PubMed ID: 32710904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing.
    Fisher AC; Kamga MH; Agarabi C; Brorson K; Lee SL; Yoon S
    Trends Biotechnol; 2019 Mar; 37(3):253-267. PubMed ID: 30241924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ionic-liquid-based approaches to improve biopharmaceuticals downstream processing and formulation.
    Almeida C; Pedro AQ; Tavares APM; Neves MC; Freire MG
    Front Bioeng Biotechnol; 2023; 11():1037436. PubMed ID: 36824351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanoscale integration of single cell biologics discovery processes using optofluidic manipulation and monitoring.
    Jorgolli M; Nevill T; Winters A; Chen I; Chong S; Lin FF; Mock M; Chen C; Le K; Tan C; Jess P; Xu H; Hamburger A; Stevens J; Munro T; Wu M; Tagari P; Miranda LP
    Biotechnol Bioeng; 2019 Sep; 116(9):2393-2411. PubMed ID: 31112285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.